BIMUF Stock Price, News & Analysis

IMPORTANT: This ticker symbol (BIMUF) is no longer in use. The company formerly known as Pascal Biosciences Inc. changed its name to Nevis Brands Inc. and now trades under different ticker symbols. This page contains historical information about the company's previous operations.

Company Overview

Pascal Biosciences Inc. was a Canadian biotechnology company headquartered in Vancouver, British Columbia, focused on developing treatments in the field of immuno-oncology. The company was formerly known as bioMmune Technologies Inc. before changing its name to Pascal Biosciences Inc. The company's name honored physicist and mathematician Blaise Pascal, reflecting its focus on bringing immunotherapy discoveries into clinical development.

Business Transformation

Pascal Biosciences underwent a complete business transformation, changing its name to Nevis Brands Inc. and pivoting from biotechnology research to the cannabis beverage industry. The company discontinued its biotech operations and now focuses on hemp-derived THC beverages. As part of this transformation, the OTC ticker symbol changed from BIMUF to PSCBF, while the company also trades on other exchanges under different symbols.

Historical Biotechnology Operations

During its time as Pascal Biosciences, the company concentrated on harnessing the body's immune system to fight cancer. The research programs addressed three main therapeutic areas: cancer, autoimmunity, and infectious diseases. The company employed proprietary screening methods to identify compounds that could reveal metastatic cancer cells to the host immune system, with several compounds demonstrating acceptable pharmacological properties in animal models of cancer.

Cancer Immunotherapy Research

The company's cancer program focused on developing therapeutics that empower the immune system to help patients suffering from life-threatening diseases. Researchers worked to identify molecules that could stimulate immune responses toward metastatic tumors. The approach centered on revealing cancer cells to the immune system rather than directly attacking tumors, representing a distinct strategy within the immuno-oncology field.

Cannabinoid Research Programs

Pascal Biosciences expanded its research portfolio to include cannabinoid-based therapeutics. The company obtained regulatory approvals to conduct cannabinoid development and established academic collaborations to advance this work. Researchers identified specific molecules in cannabis that demonstrated potential to stimulate the immune system to destroy tumor cells. The company also pursued research into cannabinoid compounds for antiviral applications, filing intellectual property related to this work.

Current Status as Nevis Brands

The company now operates as Nevis Brands Inc., headquartered in Seattle, Washington. Nevis Brands produces and licenses cannabis beverages, particularly its flagship product Major, a hemp-derived THC beverage. The company employs a licensing model to distribute its products across multiple U.S. states. Nevis Brands maintains the intellectual property portfolio from Pascal Biosciences' research and development activities, including cannabinoid therapy patents.

Trading Structure

As a Canadian company, Pascal Biosciences/Nevis Brands trades on multiple exchanges. The BIMUF ticker represented OTC trading of the company's shares when it operated as Pascal Biosciences. Investors seeking current trading information should reference the company's new ticker symbols under the Nevis Brands name. The company's primary regulatory filings occur in Canada, with OTC trading providing U.S. investor access to the shares.

Industry Context

The transformation from Pascal Biosciences to Nevis Brands represents a complete shift from the biotechnology sector to the cannabis industry. During its biotech phase, the company competed in the immuno-oncology space, which involves developing treatments that utilize the immune system to combat cancer. The pivot to cannabis beverages placed the company in the emerging market for THC-infused drinks, a growing segment within the broader cannabis industry.